←
CSL1,547 posts
CSL avatar

CSL

@CSL

Since our start in 1916, we have been driven by our promise to identify, develop and deliver innovations so our patients can live life to the fullest.

◷ Joined October 2015▧ 772 Photos and videos
CSL avatar
CSL@CSL·Aug 18

Today, we launched our FY26 full-year results. FY26 was a year of transition and setting a path to return to sustainable growth. To learn more about our results and how we’ve simplified the business and invested in our commercial capabilities, visit our Investor Centre: investors.csl.com/ #CSL

0:47
CSL avatar
CSL@CSL·Feb 10

Today we announced our half‑year results. Read the full ASX announcement for details: bit.ly/4tzf89M #CSL

Post attachment
CSL avatar
CSL@CSL·Feb 10

Today we’ve announced that Gordon Naylor has been appointed interim Chief Executive Officer and Managing Director, following Dr Paul McKenzie’s decision to retire. Read more: bit.ly/46DKj9K

Post attachment
CSL avatar
CSL@CSL·18 Nov 2025

Today, we announced an upcoming $1.5b in future U.S. capital investments, further strengthening our contribution to the U.S. healthcare ecosystem. This expansion builds on our significant U.S. presence and over $3b invested since 2018. This investment will generate hundreds of high-quality American jobs and substantially bolster U.S. manufacturing for critical plasma-derived therapies. Our goal is to meet the growing clinical need for these life-saving medicines, which are often the sole effective treatments for many rare and serious diseases. We are proud to continue investing in American innovation and talent. newsroom.csl.com/2025-11-18-… #CSL #USManufacturing #PlasmaDerivedTherapies #HealthcareInnovation #AmericanJobs

Post attachment
CSL avatar
CSL@CSL·6 Oct 2025

October is #PlasmaAwarenessMonth, an opportunity to thank our plasma donors for their generosity and to bring awareness of the important role that plasma plays in helping patients. Our plasma-derived therapies are made possible by the donation of plasma, and these therapies are used to help treat certain serious and rare conditions, including immune deficiencies and bleeding disorders. In certain medical situations, plasma-derived products may also be used in trauma care and maternal health. We encourage everyone to learn more about the #PowerofPlasma, to share the message, and consider becoming a donor themselves. Learn more here: csl.com/we-are-csl/our-busin… #CSLPlasma #PlasmaAwarenessMonth #DonatePlasma

Post attachment
CSL avatar
CSL@CSL·18 Aug 2025

Today we shared our full-year results for FY25. Take a look at some of the key financial and operational highlights. For more details visit our Investor Centre: investors.csl.com/ #CSL #FullYearResults

0:24
CSL avatar
CSL@CSL·8 Aug 2025

The first and only once-monthly treatment targeting factor XIIa to prevent recurrent attacks of #HAE has been authorized by Health Canada, offering those living with HAE a convenient administration approach. Read more: bit.ly/46MYCtN

CSL avatar
CSL@CSL·23 Jun 2025

Applications for the 2026 CSL Centenary Fellowships will close on 30 June. We are inviting Australia’s top early-mid career scientists to apply for next year’s fellowships now. bit.ly/466kBez

Post attachment
CSL avatar
CSL@CSL·18 Jun 2025

Innovation meets convenience with our first homegrown mAb to gain approval, offering a new option that may help patients manage their condition. We’re proud to bring this innovation to the HAE community. bit.ly/4jZZuOH

Post attachment
CSL avatar
CSL@CSL·17 Jun 2025

The U.S. FDA has approved the only once-monthly treatment targeting factor XIIa to prevent attacks of HAE. This reflects our commitment to HAE patients around the world, a community we have proudly supported for over four decades. Read more: bit.ly/3FFkoEI.

Post attachment
CSL avatar
CSL@CSL·23 Apr 2025

Congratulations to the eight medical researchers who have been awarded a CSL Research Acceleration Initiative (RAI) partnership to fast-track the discovery of innovative biotherapies to address unmet medical needs. bit.ly/4cLXPKw

Post attachment